Anti-NDFIP2 antibodies are used in the immunodetection of the protein Nedd4 family interacting protein 2. In humans, the canonical protein has a reported length of 336 amino acid residues and a mass of 36.4 kDa. Its subcellular localization is in the endosome and Golgi. It is reported to be expressed in the brain, lung, heart, skeletal muscle, kidney, liver and placenta. NDFIP2 is known to be involved with the transport of ions and the regulation of gene expression. Post-translational modifications have been described, including ubiquitination and phosphorylation. Synonyms for this target antigen include MAPK-activating protein PM04 PM05 PM06 PM07, NEDD4 WW domain-binding protein 5A, NF-kappa-B-activating protein 413, putative MAPK-activating protein PM04/PM05/PM06/PM07, and N4WBP5A. NDFIP2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some NDFIP2 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.